Acurx pharmaceuticals, inc. reports first quarter 2024 results and provides business update

Staten island, n.y. , may 15, 2024 /prnewswire/ -- acurx pharmaceuticals, inc. (nasdaq: acxp) ("we" or "acurx" or the "company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today certain financial and operational results for the first quarter ended march 31, 2024.

ACXP Ratings Summary

ACXP Quant Ranking